No Data
Puri Ophthalmology: 2024 Semi-Annual Report Summary
Puri Ophthalmology: 2024 Semi-Annual Report
PRICONY (301239.SZ): The net income in the first half of the year was 43.2945 million yuan, a year-on-year decrease of 81.56%.
Prui Ophthalmology (301239.SZ) released its semi-annual report for 2024, with operating revenue of 1.42 billion yuan, a year-on-year increase of 3.08%; net profit attributable to shareholders of the listed company was 43.2945 million yuan, a year-on-year decrease of 81.56%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 45.31799 million yuan, a year-on-year decrease of 69.50%; basic earnings per share was 0.29 yuan.
Is It Too Late To Consider Buying Chengdu Bright Eye Hospital Co., Ltd. (SZSE:301239)?
Chengdu Bright Eye Hospital Co., Ltd.'s (SZSE:301239) Market Cap Increased by CN¥372m, Insiders Receive a 44% Cut
Purui Ophthalmology (301239.SZ) plans to distribute 4 yuan per 10 shares, ex-dividend on July 22.
PRK Eye Care (301239.SZ) announced that the annual equity distribution for 2023 is planned to be 10 shares for every shareholder...
The Returns On Capital At Chengdu Bright Eye Hospital (SZSE:301239) Don't Inspire ConfidenceNo Data
